GET MORE AI-GENERATED SIGNALS: January 15, 2025, 11:02 am ET, BY Randall S.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Galapagos (GLPG – Research Report), with a price ...

Fintel reports that on January 23, 2025, Barclays downgraded their outlook for Galapagos NV - Depositary Receipt () (NasdaqGS:GLPG) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 48 ...

Galapagos NV (NASDAQ:GLPG – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms ...

Barclays downgraded Galapagos (GLPG) to Underweight from Equal Weight with a price target of EUR 22, down from EUR 30. With Galapagos’ ongoing ...

In trading on Thursday, shares of Galapagos NV (Symbol: GLPG) crossed above their 200 day moving average of $28.06, changing hands as high as $28.22 per share. Galapagos NV shares are currently ...

NASDAQ:GLPG opened at $23.70 on Friday. Galapagos NV has a twelve month low of $23.45 and a twelve month high of $40.34. The business’s 50-day moving average price is $26.55 and its two-hundred ...

In trading on Monday, shares of Galapagos NV (Symbol: GLPG) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $24.145 per share. By comparison ...

Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...

Belgian biotech Galapagos (NASDAQ:GLPG) announced a major restructuring drive on Wednesday, with plans to amend its 10-year collaboration with Gilead (NASDAQ:GILD) as part of its intention to ...

Integral membrane proteins carry out essential functions in the cell, and their activities are often modulated by specific protein-lipid interactions in the membrane. Here, we elucidate the intricate ...